TLX · NASDAQ · Healthcare · Biotechnology

Telix Pharmaceuticals

近一月
價格暫不可用
  • 52週區間6.28–13.11
  • 本益比126.70
  • 市值42.81億

最新消息

載入中...

簡介

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product ca...

telixpharma.com